Trials / Unknown
UnknownNCT03319290
Increase Surveillance for Breast and Ovarian Cancers, Also to Determine Targeted Risk-reducing and Preventative Strategies
Medical Provider Experience Assessment Healthcare Decisions Post-Testing, Risk Reducing, and Preventative Strategies Using BRCA2 and BRCA2 Genetic Testing
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (actual)
- Sponsor
- Data Collection Analysis Business Management · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Observational study is to increase surveillance for breast and ovarian cancers, also to determine targeted risk-reducing and preventative strategies.
Detailed description
The general design of this study is collecting data and reviewing the Principal Investigators' (P.I.) Standard Operating Procedures (SOP) on BRCA testing and changes made to their specific SOP.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | BRCA1 and BRCA2 | Genetic breast and ovarian cancer testing |
Timeline
- Start date
- 2017-10-17
- Primary completion
- 2020-10-01
- Completion
- 2020-10-17
- First posted
- 2017-10-24
- Last updated
- 2019-01-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03319290. Inclusion in this directory is not an endorsement.